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Abstract
 This is a rare case of a reactive fibrosing pseudotumor that caused small bowel volvu-
lus in a 55-year-old gentleman that resulted in small bowel resection. This case report will focus 
on the diagnosis of this rare cause of small bowel obstruction and compare the histological and 
radiological findings with that of the other commonly mistaken differential diagnoses such as 
GIST. Although this is a rare cause of small bowel volvulus this article provides comprehensive 
information across the subspecialties to aid in the diagnosis of this tumour.
 
Manuscript Information: Received: March 10, 2020; Accepted: April 06, 2020; Published: April 08, 2020
Correspondance: Kearsey CC, Department of Surgery, Royal Liverpool University Hospital, Liverpool, England.  
Email: Cck1@doctors.org.uk
Citation: Kearsey CC, McNicol F. Rare Case of Reactive Nodular Fibrous Pseudotumor Causing Small Bowel Volvulus and Obstruction. J 
Surgery. 2020; 1(1): 1005.
Copyright: ©Kearsey CC 2020. Content published in the journal follows creative common attribution license
www.journalonsurgery.org
Keywords: Gastrointestinal surgery; Clinical Histopathology; Clinical Radiology and imaging
Background
 This is a case report of a rare clinical finding of Reactive 
Nodular Fibrous Pseudotumor (RNFP) that caused small bowel 
obstruction, and according to our literature review has only been 
documented 22 times worldwide. This case report will look at the 
histological findings of the tumour and compare these to the pre-
vious cases reported in the literature. We will also look at the ra-
diology and see how this compares to documented and expected 
radiological findings outlined in other cases and highlight how 
PET CT benefits clinical practice when comparing differential di-
agnoses i.e. GIST.
Methods
 This tumour presented in a 55-year-old gentleman with 
no predisposing factors to developing malignancy and had no 
other comorbidities. He had been suffering for around 4 months 
with obstructive type symptoms particularly after meals. A CT co-
lon showed a 42x90mm lesion in the mid-illeal region which at 
first was thought to represent a Gastrointestinal Stromal Tumour 
(GIST). He went on to have further positron emission tomogra-
phy (PET) which confirmed no distant spread of the tumour and 
underwent a small bowel resection with an unremarkable recov-
ery. 
www.journalonsurgery.org          2
Discussion & literature review
 When comparing the tumour found in our patient to that 
of the cases in the literature, the tumour was large, measuring 
approximately 120mm in maximum dimensions. The tumour was 
found to centre in the mesentery, extending towards both serosal 
and luminal surfaces. Microscopically, findings were large, plump, 
fibroblast-like cells set within collagenous/kelloidal stroma lack-
ing obvious architectural pattern. There was no evidence of ne-
crosis or vascular invasion. This tumour appeared histologically 
similar to the original description of the tumour by Yantiss et al in 
2003, in particular, the hyalinised/kelloidal collagenous matrix. Al-
though this case has similarities in macro/microscopic findings, it 
does, however, appear to match in terms of immunohistochemis-
try (see Table 1). There was no CD117 staining which matched the 
majority of the previous case reports (the main difference being 
the original description in 2003). Other markers stained for were 
all negative in our tumour. These can be seen in Table 1.
 The original report by Yantiss et al (and other cases in the 
literature including our case report) demonstrated 100% positive 
results for vimentin staining in their series of 5 patients, leading 
diagnosis away from neoplastic diagnosis. Multiple other reports 
since have demonstrated similar results. Significantly, our staining 
was positively for SMA, both of which having reasonably high re-
porting in previous results and so confirmed the diagnosis. SMA, 
for example, was found in 72.7% of Daum et al.In this case, we 
did, however find differences between RNFP and GIST immuno-
histochemistry, which was the main differential diagnosis.With it 
being suggested that GISTs arise from Cajal cells, GISTs have been 
shown to have a high positive correlation to CD117 staining[7,8]. 
GISTs also have a high percentage staining for CD34 [7-9]. This 
is quite different from our tumour which had strongly negative 
CD117 and CD34 within the lesional cells. 
 Another condition that is important to consider when 
diagnosing RNFP is inflammatory myofibroblastic tumour (IMT), 
also known as inflammatory pseudotumors and inflammatory 
fibrosarcomas. They most commonly appear in the lungs, and 
there are well documented cases appearing in the mesentery and 
omentum. Macroscopic features are similar, with white/yellow 
firm masses, and some seconday changes of ulceration[10].  It 
does show a high positive immunostaining for SMA (86%), desmin 
(41%), CK (26%) and was found to stain for vimentin and CD117 
in the submesothelial areas of the tumour 10. The tumour in this 
case, was not positive for either Desmin or CK.PET-CT was per-
formed in our case (see Figure 1), as from the CT findings, there 
was concern regarding a possible diagnosis of gastrointestinal 
stromal tumour (GIST) and plans were made for surgical excision. 
We know that GISTs typically demonstrate CT findings that are 
suspicious of malignancy, it is known that GIST demonstrates high 
metabolic activity and thereby high fluorodeoxyglucose (FDG) up-
take therefore showing “hot spots” on PET-CT. Our case did not 
demonstrate high FDG uptake on PET (see Figure 1) which sug-
gests that PET-CT may be a useful imaging method for differentiat-
ing RNFP and GIST before biopsy. As this is a one-off case, further 
studies would need to be performed to look at the relationship 
between RNFP and PET-CT scanning, however this may be difficult 
due to the low number of cases of RNFP.
Learning points
 This is a case report of a rare clinical finding of reactive 
nodular fibrous pseudotumour (RNFP) that caused small bowel 
obstruction, and according to our literature review has only been 
documented 22 times worldwide. 
 This case report will look at the histological findings of 
the tumour and compare these to the previous cases reported 
in the literature.We will also look at the radiology and see how 
this compares to documented and expected radiological findings 
outlined in other cases and highlight how PET CT benefits clinical 
practice when comparing differential diagnoses i.e. GIST.
Figure 1: A comparision of the radiological finding of this case. Left is CT colon clearly showing the tumour and volvu-
lous and to the right the PET CT that showed no “hot spots”.
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Author Year Case no. Vim CD117 CD34 CK SMA Desmin
Yantiss 2003
1 + + - - + +
2 + + - - + +
3 + + - - + +
4 + + - - - -
5 + - - - - -
Daum 2004
1 + - - + +  
2 + - - + +  
3 + - - + +  
4 + - - + +  
5 + - - + +  
6 + - - + +  
7 + - - - +  
8 - - - - +  
Saglam 2005 1 + ND + + + -
Gauchotte 2009 1 + - - + + -
McAteer 2012 1 + - - + +  
Yi 2014 1 ND - + ND + -
Salihi 2014 1 ND ND ND ND ND ND
Ciftci 2015 1 + - - - + -
Yan 2015 1 + + - + ND +
This Case 2017 1 + - - - + -
  Total 77.30% 22.70% 9.10% 45.50% 72.70%  
Table 1: A review of all of the histological findings of the other reported cases of RNFP [1-6].
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